Evaluation of factors to consider prior to adjustment of biologic quality control ranges using data from a large multi-centre clinical trial Source: Annual Congress 2009 - Quality control in lung function and new developments Year: 2009
Real-world effects of lumacaftor/ivacaftor (LUM/IVA) in people with cystic fibrosis (pwCF): interim results of a long-term safety study using US CF Foundation Patient Registry (CFFPR) data Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis Year: 2021
Real-world effects of tezacaftor/ivacaftor (TEZ/IVA) in people with cystic fibrosis (pwCF): interim results of a long-term safety study using US CF Foundation Patient Registry (CFFPR) data Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis Year: 2021
Multi-centre research: The experience of a UK, Danish and Dutch qualitative study exploring the meaning of COPD and its exacerbations to patients Source: Eur Respir J 2003; 22: Suppl. 45, 66s Year: 2003
Registries: roles, objectives and registry data study outcomes Source: Eur Respir Monogr 2019; 85: 150-158 Year: 2019
Asthma quality of life in clinical trials - can we combine data from different countries? Source: Eur Respir J 2001; 18: Suppl. 33, 4s Year: 2001
Health economics of COPD: First results of the new German COSYCONET cohort compared to population-based controls from KORA Source: International Congress 2014 – Highlights in respiratory epidemiology Year: 2014
Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015
Quality of spirometries to assess possible COPD in current smokers. Results from an ongoing study in general practice in Switzerland Source: Eur Respir J 2005; 26: Suppl. 49, 55s Year: 2005
Clinical characteristics, mortality rates and causes of death in non-exacerbating COPD patients. A longitudinal cohort analysis of UK primary care data. Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies Year: 2021
Hayfever has a significant detrimental impact on national exam performance in UK teenagers: case control study Source: Eur Respir J 2005; 26: Suppl. 49, 134s Year: 2005
Evaluation of a method for establishing biologic quality control ranges from the first 20 acceptable test sessions in a large multi-center study Source: Annual Congress 2009 - Quality control in lung function and new developments Year: 2009
Does one year change in quality of life predict the mortality in patients with COPD?: Prospective cohort study Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013
Introducing the UK Biobank cohort study – what‘s in it for respiratory disease? Source: Eur Respir J 2005; 26: Suppl. 49, 597s Year: 2005
LATE-BREAKING ABSTRACT: One-year assessment of asthma control and quality of life in Europe: The liaison study (international cross-sectional and longitudinal assessment on asthma control) Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015
The primary care routine data registry BeoNet: First pilot phase results for COPD research Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes Year: 2015
A cross-sectional study on the use of information technology among people with COPD, in Sweden Source: Virtual Congress 2021 – Respiratory physiotherapy: e-health, activities of daily living and measurement properties of instruments Year: 2021
Air pollution, lung function and COPD: results from the population-based UK Biobank study Source: Eur Respir J, 54 (1) 1802140; 10.1183/13993003.02140-2018 Year: 2019
The occupations at increased risk of COPD: analysis of lifetime job-histories in the population-based UK Biobank Cohort Source: Eur Respir J, 54 (1) 1900186; 10.1183/13993003.00186-2019 Year: 2019
EXACTLE-Trial: Main results. How can EXACTLE help in AATD patients' treatment? Source: Annual Congress 2008 - EXACTLE: EXAcerbations and CT scans as Lung Endpoints in Alpha-1-Antitrypsin Deficiency Year: 2008